# Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct

> **NCT00010088** · PHASE2 · UNKNOWN · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group**

## Conditions studied

- Extrahepatic Bile Duct Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** leucovorin calcium
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00010088
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010088, "Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00010088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*